Abstract
This chapter introduces the emerging field of metabolomics and its application in the context of cancer biomarker research. Taking advantage of modern high-throughput technologies, and enhanced computational power, metabolomics has a high potential for cancer biomarker identification and the development of diagnostic tools. This chapter describes current metabolomics technologies used in cancer research, starting with metabolomics sample preparation, elaborating on current analytical methodologies for metabolomics measurement and introducing existing software for data analysis. The last part of this chapter deals with the statistical analysis of very large metabolomics datasets and their relevance for cancer biomarker identification.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Koppenol WH, Bounds PL, Dang CV (2011) Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 11:325–337
Warburg O (1956) On the origin of cancer cells. Science 123:309–314
Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029–1033
Lu W, Bennett BD, Rabinowitz JD (2008) Analytical strategies for LC-MS-based targeted metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci 871:236–242
Ludwig C, Ward DG, Martin A, Viant MR, Ismail T, Johnson PJ, Wakelam MJ, Gunther UL (2009) Fast targeted multidimensional NMR metabolomics of colorectal cancer. Magn Reson Chem 47(Suppl 1):S68–S73
Villas-Boas SG, Mas S, Akesson M, Smedsgaard J, Nielsen J (2005) Mass spectrometry in metabolome analysis. Mass Spectrom Rev 24:613–646
Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S et al (2007) HMDB: the human metabolome database. Nucleic Acids Res 35:D521–D526
Lu J-J, Bao J-L, Wu G-S, Xu W-S, Huang M-Q, Chen X-P, Wang Y-T (2013) Quinones derived from plant secondary metabolites as anti-cancer agents. Anticancer Agents Med Chem 13:456–463
Bothwell JH, Griffin JL (2011) An introduction to biological nuclear magnetic resonance spectroscopy. Biol Rev Camb Philos Soc 86:493–510
Bathe OF, Shaykhutdinov R, Kopciuk K, Weljie AM, McKay A, Sutherland FR, Dixon E, Dunse N, Sotiropoulos D, Vogel HJ (2011) Feasibility of identifying pancreatic cancer based on serum metabolomics. Cancer Epidemiol Biomarkers Prev 20:140–147
Monleon D, Morales JM, Barrasa A, Lopez JA, Vazquez C, Celda B (2009) Metabolite profiling of fecal water extracts from human colorectal cancer. NMR Biomed 22:342–348
Tiziani S, Lopes V, Gunther UL (2009) Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 11:269–276, 264p following 269
Weljie AM, Bondareva A, Zang P, Jirik FR (2011) 1H NMR metabolomics identification of markers of hypoxia-induced metabolic shifts in a breast cancer model system. J Biomol NMR 49:185–193
Villas-Boas SG, Nielsen J, Smedsgaard J, Hansen MA, Roessner-Tunali U (2007) Metabolome analysis: an introduction, vol 24. Wiley, Hoboken
Wilson ID, Plumb R, Granger J, Major H, Williams R, Lenz EM (2005) HPLC-MS-based methods for the study of metabonomics. J Chromatogr B 817:67–76
Smith RD, Loo JA, Edmonds CG, Barinaga CJ, Udseth HR (1990) New developments in biochemical mass spectrometry: electrospray ionization. Anal Chem 62:882–899
March RE (1997) An introduction to quadrupole ion trap mass spectrometry. J Mass Spectrom 32:351–369
Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Graham Cooks R (2005) The Orbitrap: a new mass spectrometer. J Mass Spectrom 40:430–443
Amster IJ (1996) Fourier transform mass spectrometry. J Mass Spectrom 31:1325–1337
Zhang G, Panigrahy D, Mahakian LM, Yang J, Liu JY, Stephen Lee KS, Wettersten HI, Ulu A, Hu X, Tam S et al (2013) Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci U S A 110:6530–6535
Bernini P, Bertini I, Luchinat C, Nincheri P, Staderini S, Turano P (2011) Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks. J Biomol NMR 49:231–243
de Jonge LP, Douma RD, Heijnen JJ, van Gulik WM (2012) Optimization of cold methanol quenching for quantitative metabolomics of Penicillium chrysogenum. Metabolomics 8:727–735
Sellick CA, Knight D, Croxford AS, Maqsood AR, Stephens GM, Goodacre R, Dickson AJ (2010) Evaluation of extraction processes for intracellular metabolite profiling of mammalian cells: matching extraction approaches to cell type and metabolite targets. Metabolomics 6:427–438
Yu Z, Kastenmüller G, He Y, Belcredi P, Möller G, Prehn C, Mendes J, Wahl S, Roemisch-Margl W, Ceglarek U (2011) Differences between human plasma and serum metabolite profiles. PLoS One 6:e21230
Li S, Guo B, Song J, Deng X, Cong Y, Li P, Zhao K, Liu L, Xiao G, Xu F (2013) Plasma choline-containing phospholipids: potential biomarkers for colorectal cancer progression. Metabolomics 9:202–212
Nishiumi S, Kobayashi T, Ikeda A, Yoshie T, Kibi M, Izumi Y, Okuno T, Hayashi N, Kawano S, Takenawa T (2012) A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 7:e40459
Ganti S, Taylor SL, Kim K, Hoppel CL, Guo L, Yang J, Evans C, Weiss RH (2012) Urinary acylcarnitines are altered in human kidney cancer. Int J Cancer 130:2791–2800
Xie GX, Chen TL, Qiu YP, Shi P, Zheng XJ, Su MM, Zhao AH, Zhou ZT, Jia W (2012) Urine metabolite profiling offers potential early diagnosis of oral cancer. Metabolomics 8:220–231
Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fu H, Weljie A, Jha N, Slupsky C (2009) Understanding the human salivary metabolome. NMR Biomed 22:577–584
de Weerth C, Jansen J, Vos MH, Maitimu I, Lentjes EG (2007) A new device for collecting saliva for cortisol determination. Psychoneuroendocrinology 32:1144–1148
Wei J, Xie G, Zhou Z, Shi P, Qiu Y, Zheng X, Chen T, Su M, Zhao A, Jia W (2011) Salivary metabolite signatures of oral cancer and leukoplakia. Int J Cancer 129:2207–2217
Crews B, Wikoff WR, Patti GJ, Woo H-K, Kalisiak E, Heideker J, Siuzdak G (2009) Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data. Anal Chem 81:8538–8544
Nakamizo S, Sasayama T, Shinohara M, Irino Y, Nishiumi S, Nishihara M, Tanaka H, Tanaka K, Mizukawa K, Itoh T (2013) GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients. J Neuro Oncol 113(1):65–74
Pedrioli PG, Eng JK, Hubley R, Vogelzang M, Deutsch EW, Raught B, Pratt B, Nilsson E, Angeletti RH, Apweiler R (2004) A common open representation of mass spectrometry data and its application to proteomics research. Nat Biotechnol 22:1459–1466
Hiller K, Hangebrauk J, Jäger C, Spura J, Schreiber K, Schomburg D (2009) MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC/MS based metabolome analysis. Anal Chem 81:3429–3439
Stein SE (1999) An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data. J Am Soc Mass Spectrom 10:770–781
Sugimoto M, Kawakami M, Robert M, Soga T, Tomita M (2012) Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis. Curr Bioinform 7:96
Kovàts ES (1961) Zusammenhänge zwischen Struktur und gasehromatographischen Daten organischer Verbindungen. Fresenius J Anal Chem 181:351–364
Izquierdo-García J, Rodríguez I, Kyriazis A, Villa P, Barreiro P, Desco M, Ruiz-Cabello J (2009) A novel R-package graphic user interface for the analysis of metabonomic profiles. BMC Bioinformatics 10:363
Benton H, Wong D, Trauger S, Siuzdak G (2008) XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization. Anal Chem 80:6382–6389
Biswas A, Mynampati KC, Umashankar S, Reuben S, Parab G, Rao R, Kannan VS, Swarup S (2010) MetDAT: a modular and workflow-based free online pipeline for mass spectrometry data processing, analysis and interpretation. Bioinformatics 26:2639–2640
Lommen A (2009) MetAlign: interface-driven, versatile metabolomics tool for hyphenated full-scan mass spectrometry data preprocessing. Anal Chem 81:3079–3086
Bunk B, Kucklick M, Jonas R, Münch R, Schobert M, Jahn D, Hiller K (2006) MetaQuant: a tool for the automatic quantification of GC/MS-based metabolome data. Bioinformatics 22:2962–2965
Melamud E, Vastag L, Rabinowitz JD (2010) Metabolomic analysis and visualization engine for LC−MS data. Anal Chem 82:9818–9826
Babushok V, Linstrom P, Reed J, Zenkevich I, Brown R, Mallard W, Stein S (2007) Development of a database of gas chromatographic retention properties of organic compounds. J Chromatogr A 1157:414–421
Kind T, Wohlgemuth G, Lee DY, Lu Y, Palazoglu M, Shahbaz S, Fiehn O (2009) FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 81:10038–10048
Kopka J, Schauer N, Krueger S, Birkemeyer C, Usadel B, Bergmüller E, Dörmann P, Weckwerth W, Gibon Y, Stitt M (2005) GMD@ CSB. DB: the Golm metabolome database. Bioinformatics 21:1635–1638
Smith CA, O’Maille G, Want EJ, Qin C, Trauger SA, Brandon TR, Custodio DE, Abagyan R, Siuzdak G (2005) METLIN: a metabolite mass spectral database. Ther Drug Monit 27:747–751
van den Berg RA, Hoefsloot HC, Westerhuis JA, Smilde AK, van der Werf MJ (2006) Centering, scaling, and transformations: improving the biological information content of metabolomics data. BMC Genomics 7:142
Hastie T, Tibshirani R, Friedman J (2009) The elements of statistical learnin. Springer, New York
Jolliffe IT (2002) Principal component analysis, 2nd edn. Springer, New York
Katajamaa M, Orešič M (2007) Data processing for mass spectrometry-based metabolomics. J Chromatogr A 1158:318–328
Lee JJA, Verleysen M (2007) Nonlinear dimensionality reduction. Springer, New York/London
Van der Maaten, LJP (2013) Barnes-Hut SNE. In: Proceedings of the international conference on learning representations, Scottsdale, Arizona (USA)
Bottou L (2010) Large-Scale machine learning with stochastic gradient descent. In: Proceedings of the 19th international conference on computational statistics, Paris (France)
Koh K, Kim S-J, Boyd SP (2007) An interior-point method for large-scale l1-regularized logistic regression. J Mach Learn Res 8:1519–1555
Vapnik V (1995) The nature of statistical learn theory. Springer, New York
Goodacre R, Broadhurst D, Smilde AK, Kristal BS, Baker JD, Beger R, Bessant C, Connor S, Capuani G, Craig A (2007) Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics 3:231–241
Guyon I, Elisseeff A (2003) An introduction to variable and feature selection. J Mach Learn Res 3:1157–1182
Ambroise C, McLachlan G (2002) Selection bias in gene extraction on the basis of microarray gene-expression data. Proc Natl Acad Sci 99:6562–6566
Tibshirani R (1996) Regression shrinkage and selection via the lasso. J R Stat Soc Series B Stat Methodol 58(1):267–288
Tibshirani R, Saunders M, Rosset S, Zhu J, Knight K (2005) Sparsity and smoothness via the fused lasso. J R Stat Soc Series B Stat Methodol 67:91–108
Bach F, Jenatton R, Mairal J, Obozinski G (2012) Structured sparsity through convex optimization. Stat Sci 27:450–468
Acknowledgments
The authors thank Dr. Christian Jäger for the critical review of the book chapter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Trezzi, JP., Vlassis, N., Hiller, K. (2015). The Role of Metabolomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools. In: Scatena, R. (eds) Advances in Cancer Biomarkers. Advances in Experimental Medicine and Biology, vol 867. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7215-0_4
Download citation
DOI: https://doi.org/10.1007/978-94-017-7215-0_4
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7214-3
Online ISBN: 978-94-017-7215-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)